Performance of automatic image segmentation algorithms for calculating total lesion glycolysis for early response monitoring in non-small cell lung cancer patients during concomitant chemoradiotherapy

被引:18
|
作者
Grootjans, Willem [1 ,2 ]
Usmanij, Edwin A. [1 ]
Oyen, Wim J. G. [1 ,3 ,4 ]
van der Heijden, Erik H. F. M. [5 ]
Visser, Eric P. [1 ]
Visvikis, Dimitris [6 ]
Hatt, Mathieu [6 ]
Bussink, Johan [7 ]
de Geus-Oei, Lioe-Fee [1 ,2 ,8 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dept Radiol & Nucl Med, Nijmegen, Netherlands
[2] Leiden Univ, Med Ctr, Dept Radiol, POB 9600, NL-2300 RC Leiden, Netherlands
[3] Inst Canc Res, London, England
[4] Royal Marsden NHS Fdn Trust, London, England
[5] Radboud Univ Nijmegen, Med Ctr, Dept Pulm Med, Nijmegen, Netherlands
[6] INSERM, UMR 1101, Lab Traitement Informat Med LaTIM, Brest, France
[7] Radboud Univ Nijmegen, Med Ctr, Dept Radiat Oncol, Nijmegen, Netherlands
[8] Univ Twente, MIRA Inst, Biomed Photon Imaging Grp, Enschede, Netherlands
关键词
Early response monitoring; Non-small cell lung cancer; Concomitant chemoradiochemotherapy; F-18-FDG PET/CT; Total lesion glycolysis; Automatic image segmentation; TARGET VOLUME DELINEATION; RADIOTHERAPY FDG-PET; F-18-FDG PET; PROGNOSTIC VALUE; DOSE-ESCALATION; SURVIVAL; FAILURE; IMPACT; NSCLC; AREAS;
D O I
10.1016/j.radonc.2016.04.039
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and purpose: This study evaluated the use of total lesion glycolysis (TLG) determined by different automatic segmentation algorithms, for early response monitoring in non-small cell lung cancer (NSCLC) patients during concomitant chemoradiotherapy. Materials and methods: Twenty-seven patients with locally advanced NSCLC treated with concomitant chemoradiotherapy underwent F-18-fluorodeoxyglucose (FDG) PET/CT imaging before and in the second week of treatment. Segmentation of the primary tumours and lymph nodes was performed using fixed threshold segmentation at (i) 40% SUVmax (T40), (ii) 50% SUVmax (T50), (iii) relative-threshold-level (RTL), (iv) signal-to-background ratio (SBR), and (v) fuzzy locally adaptive Bayesian (FLAB) segmentation. Association of primary tumour TLG (TLGT), lymph node TLG (TLGLN), summed TLG (TLG(S) = TLG(T) + TLG(LN)), and relative TLG decrease (Delta TLG) with overall -survival (OS) and progression-free survival (PFS) was determined using univariate Cox regression models. Results: Pretreatment TLG(T) was predictive for PFS and OS, irrespective of the segmentation method used. Inclusion of TLG(LN) improved disease and early response assessment, with pretreatment TLG(S) more strongly associated with PFS and OS than TLG(T) for all segmentation algorithms. This was also the case for Delta TLG(S), which was significantly associated with PFS and OS, with the exception of RTL and T40. Conclusions: Delta TLG(S) was significantly associated with PFS and OS, except for RTL and T40. Inclusion of TLG(LN) improves early treatment response monitoring during concomitant chemoradiotherapy with FDG-PET. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:473 / 479
页数:13
相关论文
共 50 条
  • [41] Effect analysis of chemoradiotherapy after operation in patients with stage ⅢA non-small cell lung cancer
    Sheng Chen
    Yu-Ling Cheng
    Shi-Ting Li
    Yao-Jun Ni
    Biao Gu
    Asian Pacific Journal of Tropical Medicine, 2012, (10) : 823 - 827
  • [42] Effect of Tumor Size on Prognosis in Patients Treated with Radical Radiotherapy or Chemoradiotherapy for Non-Small Cell Lung Cancer
    Ball, David
    Mitchell, Alan
    Giroux, Dori
    Rami-Porta, Ramon
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (03) : 315 - 321
  • [43] Outcomes of Concurrent Chemoradiotherapy in Elderly Patients with Stage III Non-Small Cell Lung Cancer
    Lee, Seok Ho
    Lee, Seung Heon
    Heo, Ho-Jin
    Sung, Kihoon
    Lee, Kyu Chan
    Jung, Sung Hwan
    Park, Jeong Woong
    Cho, Eun Kyung
    Ahn, Hee Kyung
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S685 - S685
  • [44] Concomitant Chemoradiotherapy and Antiretroviral Therapy for HIV-Infected Patients with Locoregionally Advanced Non-Small Cell Lung Cancer: Benefit and Tolerability of Treatment in 2 Cases
    Okuma, Yusuke
    Yanagisawa, Naoki
    Hosomi, Yukio
    Imamura, Akifumi
    Okamura, Tatsuru
    Kato, Kan
    Negishi, Kyota
    ONKOLOGIE, 2013, 36 (10): : 586 - 590
  • [45] Concomitant chemoradiotherapy with docetaxel and cisplatin followed by consolidation chemotherapy in locally advanced unresectable non-small cell lung cancer
    Eroglu, Celalettin
    Orhan, Okan
    Unal, Dilek
    Dogu, Gamze G.
    Karaca, Halit
    Dikilitas, Mustafa
    Ozturk, Ahmet
    Ozkan, Metin
    Kaplan, Bunyamin
    ANNALS OF THORACIC MEDICINE, 2013, 8 (02) : 109 - 115
  • [46] Exploring causes and consequences of early discontinuation of durvalumab after chemoradiotherapy for non-small cell lung cancer
    Pennock, Michael
    Halmos, Balazs
    Bodner, William
    Cheng, Haiying
    Gucalp, Rasim
    Ohri, Nitin
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2023, 41
  • [47] 18F-FDG PET/CT total lesion glycolysis is associated with circulating tumor cell counts in patients with stage I to IIIA non-small cell lung cancer
    Avella, Diego M.
    Manjunath, Yariswamy
    Singh, Amolak
    Deroche, Chelsea B.
    Kimchi, Eric T.
    Staveley-O'Carroll, Kevin F.
    Mitchem, Jonathan B.
    Kwon, Eric
    Li, Guangfu
    Kaifi, Jussuf T.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (03) : 515 - 521
  • [48] Impact of early palliative interventions on the outcomes of care for patients with non-small cell lung cancer
    Nieder, Carsten
    Tollali, Terje
    Haukland, Ellinor
    Reigstad, Anne
    Flatoy, Liv Randi
    Engljahringer, Kirsten
    SUPPORTIVE CARE IN CANCER, 2016, 24 (10) : 4385 - 4391
  • [49] Adjuvant Chemotherapy in Elderly Patients with Early-stage Non-small Cell Lung Cancer
    Kefeli, Umut
    Kaymaz, Samet
    Aydin, Dincer
    Isik, Deniz
    Cabuk, Devrim
    Sonkaya, Alper
    Acikgoz, Ozgur
    Isik, Ulas
    Ozden, Ercan
    Uygun, Kazim
    BEZMIALEM SCIENCE, 2019, 7 (04): : 265 - 270
  • [50] Diagnosis of Non-small Cell Lung Cancer for Early Stage Asymptomatic Patients
    Goebel, Cherylle
    Louden, Christopher L.
    Mckenna, Robert, Jr.
    Onugha, Osita
    Wachtel, Andrew
    Long, Thomas
    CANCER GENOMICS & PROTEOMICS, 2019, 16 (04) : 229 - 244